Pensar Medical gets Premier breakthrough designation for MicroDoc negative pressure wound therapy

Pensar Medical’s MicroDoc has earned Premier Inc.’s Breakthrough Technology Designation for negative pressure wound therapy, giving Premier members access to pre-negotiated pricing and terms starting June 1, 2026. The deal could broaden MicroDoc’s reach across hospitals and ambulatory surgery centers while underscoring demand for surgical-site infection prevention tools. Why it matters: - Premier’s designation can speed adoption of MicroDoc across its member network by pairing the device with special pricing and terms. - Pensar Medical is positioning MicroDoc as a differentiated option in the surgical negative pressure wound therapy market, where clinicians are looking for tools that may improve healing and reduce infection risk. - Surgical site infections cost the U.S. healthcare system more than $3.3 billion each year. What happened: - Pensar Medical’s MicroDoc received Premier Inc.’s Breakthrough Technology Designation for negative pressure wound therapy. - The agreement took effect June 1, 2026. - Premier members can choose to use pre-negotiated pricing and terms for MicroDoc. - Pensar Medical announced the news June 18, 2026, in Houston. The details: - Premier uses the designation for innovations that offer major gains in patient safety, clinical outcomes and operational efficiency. - MicroDoc is designed to treat open wounds and support post-surgical incisional management. - Pensar Medical says MicroDoc is the only device in the sNPWT category that offers customizable negative pressure settings. - The company said MicroDoc serves a category with a $1.2 billion total addressable market and more than 11% compound annual growth. - Pensar Medical said clinical research shows sNPWT can lower surgical site infections and improve healing. - Pensar Medical said sNPWT devices like MicroDoc have been shown to cut surgical site infection risk by more than half. - Jon Olson, Pensar Medical president and COO, said the Premier contract expands the company’s hospital and ambulatory surgery center customer base. - Olson also said the deal supports Pensar Medical’s sales and service distribution network of more than 250 representatives. - Pensar Medical offers MicroDoc alongside WoundPro and WoundPro+ through authorized distributors. - Pensar Medical was founded in 2012 and focuses on wound care and negative pressure wound therapy. - Premier is headquartered in Charlotte, North Carolina, and provides data and analytics, collaboratives, supply chain solutions and advisory services. Between the lines: - The Premier designation gives Pensar Medical a credibility boost with health systems that often use group purchasing and contract vehicles to guide procurement. - The company is tying MicroDoc’s commercial pitch to both clinical outcomes and operating efficiency, which are key buying criteria for hospitals and surgery centers. - The emphasis on customizable settings suggests Pensar Medical is aiming to stand out in a crowded wound-care category with a product differentiation story. What’s next: - Premier members can decide whether to adopt MicroDoc under the new contract terms. - Pensar Medical expects the agreement to accelerate sales growth as it expands across hospital and ASC channels. - The company is likely to lean on the Premier relationship as part of its broader distribution strategy. The bottom line: - The Premier designation gives Pensar Medical a stronger sales channel for MicroDoc and reinforces the company’s push to win share in wound care through clinical and operational claims.